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Abstract
Background: Non-tunneled (temporary) hemodialysis catheters (NTHCs) are the least-optimal initial vascular access
for incident maintenance hemodialysis patients yet little is known about factors associated with NTHC use in this
context. We sought to determine factors associated with NTHC use and examine regional and facility-level variation
in NTHC use for incident maintenance hemodialysis patients.
Methods: We analyzed registry data collected between January 2001 and December 2010 from 61 dialysis
facilities within 12 geographic regions in Canada. Multi-level models and intra-class correlation coefficients
were used to evaluate variation in NTHC use as initial hemodialysis access across facilities and geographic
regions. Facility and patient characteristics associated with the lowest and highest quartiles of NTHC use
were compared.
Results: During the study period, 21,052 patients initiated maintenance hemodialysis using a central venous
catheter (CVC). This included 10,183 patients (48.3 %) in whom the initial CVC was a NTHC, as opposed to a
tunneled CVC. Crude variation in NTHC use across facilities ranged from 3.7 to 99.4 % and across geographic
regions from 32.4 to 85.1 %. In an adjusted multi-level logistic regression model, the proportion of total variation
in NTHC use explained by facility-level and regional variation was 40.0 % and 34.1 %, respectively. Similar results
were observed for the subgroup of patients who received greater than 12 months of pre-dialysis nephrology
care. Patient-level factors associated with increased NTHC use were male gender, history of angina, pulmonary
edema, COPD, hypertension, increasing distance from dialysis facility, higher serum phosphate, lower serum
albumin and later calendar year.
Conclusions: There is wide variation in NTHC use as initial vascular access for incident maintenance hemodialysis
patients across facilities and geographic regions in Canada. Identifying modifiable factors that explain this
variation could facilitate a reduction of NTHC use in favor of more optimal initial vascular access.
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Background
Non-tunneled (temporary) hemodialysis catheters (NTHCs)
are the preferred initial vascular access for patients with
acute kidney injury (AKI) [1]. However, for patients initiat-
ing chronic hemodialysis, NTHCs are the least optimal
initial vascular access [2–4]. In this situation, the insertion
of a NTHC is an additional procedure, with risks of ser-
ious complications [3], for patients who will subsequently
require another procedure to establish permanent vascular
access anyway. Similar to what has been well described for
tunneled catheters [3], likely related to consequent central
venous stenosis [1], there is some evidence to suggest that
initial use of a NTHC is associated with later vascular ac-
cess complications such as arteriovenous fistula (AVF)
thrombosis [5].
Despite efforts aimed at improving access to and
provision of pre-dialysis nephrology care to minimize
the use of central venous catheters (CVCs) (tunneled
CVCs and NTHCs) [6], CVCs remain the initial vascu-
lar access for up to 80 % of chronic hemodialysis
patients in Canada [7]. Little is known about the use of
NTHCs as previous studies have not distinguished be-
tween tunneled CVCs and NTHCs [8–10].
Regional variation in dialysis practices, either at the
facility or geographic level, has been well documented
in Canada and other jurisdictions [11–20]. Interven-
tions targeting a reduction in measured practice vari-
ation have translated into improvements in patient care
[18, 19]. As such, quantitating practice variation for key
dialysis performance metrics, such as vascular access,
could facilitate the development of programs and pol-
icies to improve care. To our knowledge, no studies
have sought to examine practice variation in NTHC
use in patients starting maintenance hemodialysis. In
this study, we set out to measure facility and geo-
graphic variation for the initial use of NTHCs and de-
termine the factors among patients and facilities that
are associated with greater NTHC use. Identification of
these factors and subsequently classifying them as ei-
ther modifiable or non-modifiable would potentially
help in planning and implementation of process mea-
sures designed to reduce variation.
Methods
Population and data sources
All adult (>18 years old) patients who started mainten-
ance hemodialysis with a CVC from January 2001 to
December 2010, captured in the Canadian Organ Replace-
ment Registry (CORR), were included in our study. CORR
is a validated registry that includes information (patient
demographics, comorbidities, modality of RRT, transplant-
ation, vascular access type and survival statistics) on all
end stage kidney disease (ESKD) patients in Canada
(excluding the province of Québec) who start on dialysis
[21, 22]. Ethics approval was obtained from the Ottawa
Health Science Network Research Ethics Board. Use of
CORR was approved by the Canadian Institute for Health
Information (CIHI).
Definitions
Vascular access was defined as the vascular access used
for the first hemodialysis treatment. Patients using an
arteriovenous fistula (AVF) or graft (AVG) were ex-
cluded, as were patients with a co-existing AVF or AVG
and CVC. CVCs are prospectively coded within CORR
as either being NTHCs or tunneled CVCs. Data regard-
ing the side (right/left) and anatomical site of catheter
placement (i.e. internal jugular, subclavian or femoral)
is unavailable in the registry. First visit date with a neph-
rologist was used to estimate the length of pre-dialysis
nephrology care and categorized as either greater or less
than 1 year prior to first dialysis. Distance to facility was
defined as less than 50, 50 to 150 and greater than 150
kilometers, using previously published methods [23]. Indi-
vidual patients and dialysis facilities were de-identified for
analytic purposes. The presence of co-morbidities (angina,
chronic obstructive pulmonary disease, diabetes, malig-
nancy, serious illness, hypertension, lung disease, coronary
artery bypass grafting, pulmonary edema, peripheral vascu-
lar disease, stroke, cigarette smoker, acute coronary syn-
drome) and laboratory values immediately prior to dialysis
initiation (hemoglobin, albumin, phosphate) are captured
within CORR.
Since dialysis care may vary across facilities, facility
level variables were created based on clinical relevance,
known association with outcomes, and quality of care
indicators [24–27]. Facility-level variables included
whether or not the facility offered kidney transplantation
or peritoneal dialysis, mean hemoglobin and phosphate
of a facility’s patients at dialysis initiation, average dis-
tance in kilometers between a facility’s patients’ primary
residences and nearest dialysis facility, center size and
average estimated glomerular filtration rate (eGFR) at
dialysis initiation. Information on patients geographic
regions was included and categorized into 12 regions as
Atlantic, Northern Ontario, Greater Toronto, Eastern
Ontario, Western Ontario, Manitoba, Saskatchewan,
Northern Alberta, Southern Alberta, Eastern British
Columbia, Vancouver and Other British Columbia re-
gions. Facilities with 10 or less patients during the en-
tire study period were excluded. Multiple imputation
was employed for missing values [28].
Statistical analysis
Patient and facility characteristics were compared be-
tween patients who were started on dialysis with a
NTHC or tunneled CVC. Continuous variables of interest
were summarized using the mean with standard deviation.
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Differences in characteristics were determined by the Stu-
dent’s t-test for continuous variables and the chi-square
for dichotomous variables.
Facility and geographic variation were examined
using a three level, multilevel model and to assess pre-
dictors associated with a NTHC. Models were adjusted
for factors thought to potentially influence decisions to
initiate dialysis including facility level factors (trans-
plantation facility, peritoneal dialysis facility, average
hemoglobin and phosphate, average distance a patient
resided from the nearest dialysis facility and number of
HD patients treated at the facility, average eGFR at
dialysis initiation), patient case mix (age, sex, body
mass index, race, co-morbidities, distance to facility,
serum phosphate, albumin and hemoglobin, eGFR at
dialysis initiation) and calendar year. Facility and geo-
graphic variation were determined by the intra-class
correlation coefficient (ICC) [29]. The intra-class cor-
relation coefficients were calculated by dividing the
variance estimate at each level by the total model vari-
ance. In our study the intra-class correlation coeffi-
cient determines the proportion of explained variation
in the use of a NTHC at dialysis initiation that is due
to being a member of a particular group such as pa-
tient, facility and geographic region and is reported as
a percentage. Facility-level variables were centered for
the facility-averages [30]. The R2 used to determine the
percentage of variation explained at each level for the full
and reduced models was determined by the Raudenbush
and Byrk method, whereas the R2 for the total model was
determined by the Snijder and Bosker method [31, 32].
We employed the SAS GLIMMIX procedure (SAS 9.2)
using a logit link and employing latent variable ap-
proach at the patient level [30]. In this model the intra-
class correlation coefficients were calculated for the
facility and geographic regions by assuming a patient-
level variance of π2/3 [33, 34]. To interrogate the
patient-level variance assumption of π2/3, the ICC was
further calculated using a probit link assuming a patient
level variance of 1. We calculated the odds ratios for
initiation with a NTHC by geographic region in a sep-
arate 2-level multilevel logistic model adjusted for pa-
tient case mix and facility-level factors listed previously.
As it has been established that late nephrology referral
is associated with significantly greater CVC use [35],
we conducted an additional analysis limiting our cohort
only to patients with pre-dialysis care > 365 days (i.e.
excluding patients with shorter duration of pre-dialysis
care).
Lastly, we categorized the facilities into quartiles of
NTHC use and compared patient and facility character-
istics associated with the highest and lowest quartiles for
NTHC use. Analyses were performed using SAS version
9.2 (SAS Inc, Cary NC).
Results
During the study period, 21,052 patients began chronic
dialysis with a CVC, of which 10,183 (48.3 %) were
NTHCs. Table 1 details baseline patient, facility and geo-
graphic characteristics of the study cohort according
whether initial vascular access was a NTHC or a tunneled
permanent HD catheter. Patients with a NTHC were less
likely to be Caucasian, have shorter pre-dialysis care, have
a history of vascular disease and pulmonary edema, have
more laboratory abnormalities and reside further from a
dialysis facility. Facilities characteristics associated with
NTHC use included less likely to be a peritoneal dialysis
or transplantation facility and less incident patients.
Crude variation in NTHC use across 61 facilities ranged
from 3.7 to 99.4 % and across geographic regions from
32.4 to 85.1 %. Fig. 1 shows NTHC use as a percentage of
crude CVC use (NTHCs and tunneled HD catheters)
across all geographic regions.
Table 2 reports the unadjusted and adjusted attribut-
able variation at the facility and geographic-level for ini-
tiation of hemodialysis with a NTHC. In the multi-level
logistic regression model, the explained variation at the
facility level was 43.9 % unadjusted and 40.0 % adjusted
(p < 0.0001). Explained variation at the regional levels
was 21.8 % and 34.1 % (p = 0.1), respectively. Similar
results were observed for the subgroup of patients who
received >1 year of pre-dialysis nephrology care with
explained variation of 46 % and 38.1 % at the facility and
regional levels, respectively (data not shown). Fig. 2 shows
the adjusted odds ratios for initial NTHC use across
Canada in which adjusted odds ratios ranged from 0.59
(95 % CI, 0.49-0.71) in the Atlantic region to 9.26 (95 %
CI, 6.81-12.58) in BC (Other) with Saskatchewan as the
reference group.
Patient and facility characteristics for those facilities
within the highest and lowest quartiles of NTHC use at
dialysis initiation are compared in Table 3. In general,
patients treated at facilities with the lowest quartile of
NTHC use were younger, less likely to be Caucasian,
had longer pre-dialysis care and lower eGFR at dialysis
initiation. Conversely, patients at facilities in the high-
est quartile of NTHC use were more likely to have a
history of pulmonary edema, stroke, cigarette smoking,
PVD, serious illness, reside rurally and less likely to
have diabetes, angina or ESRD due to diabetes. Facil-
ities in the top quartile of NTHC use had fewer inci-
dent patients, and were less likely to be a transplant or
peritoneal dialysis facility.
The extent to which patient and facility level variables
were associated with incident NTHC use within the fully
adjusted model are reported in Table 4. Lower number
of incident patients per facility, male sex, a history of an-
gina, pulmonary edema, lung disease, residing a further
distance from a dialysis facility, higher eGFR at dialysis
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Table 1 Baseline patient, facility and geographic characteristics of the study cohort according to individuals who initiated dialysis
with non-tunneled temporary vs. tunneled hemodialysis catheters
Characteristic
NTHC tCVC pvalue
N 10, 162 (48.3) 10,890 (51.7)
Patient Characteristics:
Age (± SD) 64.6 ± 15.5 64.6 ± 16.2 0.705
Sex % male 59.4 57.4 0.004
BMI (± SD) 27.3 ± 6.6 27.5 ± 6.7 0.052
Race (%) <0.001
Caucasian 70.9 74.2
East Asian 5.9 5.1
Aboriginal 7.8 6.1




Pre-dialysis care >90 days % 53.2 64.3 <0.001
Pre-dialysis care >365 days % 34.2 45.6
Co-morbidities: %
Angina 27.2 23.9 <0.001
Acute coronary syndrome 26.5 24.8 0.003
Pulmonary edema 34.1 29.4 <0.001
Diabetes mellitus 46.7 49.3 <0.001
Stroke 16.9 16.5 0.437
Peripheral vascular disease 23.3 21.6 0.003
Malignancy 15.1 15.3 0.788
Lung disease 14.9 13.4 0.002
Any hypertension medication(s) 81.3 85.6 <0.001
Current smoker 16.9 15.7 0.034
CABG 16.4 16.4 0.970
Serious Illness 16.0 16.2 0.708
Cause of ESRD % <0.001
Hypertension 23.6 21.4




Polycystic kidney disease 1.8 2.8
Other 13.1 8.6
Unknown 9.5 9.2
eGFR at dialysis initiation (± SD) 9.6 ± 4.7 9.6 ± 4.4 0.435
Hemoglobin g/L (mean ± SD) 97.5 ± 17.7 98.9 ± 16.9 <0.001
Phosphatemmol/L (mean ± SD) 2.0 ± 0.8 2.0 ± 0.7 <0.001
Albumin g/L (mean ± SD) 30.3 ± 0.9 30.7 ± 0.9 <0.001
Distance from facility % <0.001
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initiation, and higher serum phosphate were independ-
ently associated with NTHC use.
Discussion
This Canadian cohort study of over 20,000 hemodialysis
patients who started dialysis between 2001 and 2010 is the
first to describe patient and facility level factors associated
with starting chronic hemodialysis using a NTHC. The
most striking finding is the extent to which initial NTHC
use varies across facilities and regions. After adjustment
for patient-level factors (case-mix) and facility-level quality
indicators, otherwise unspecified center-level factors
accounted for 40 % of total variation and regional-level
factors accounted for an additional 34 %. This is much
higher than the extent to which center-level and regional-
level factors explain variation for other dialysis practices
in Canada such as eGFR at time of dialysis initiation
(3.1 % and 0.0 %, respectively) [17] and initial use of
peritoneal dialysis (9.3 % and 3.4 %, respectively) [36]. For
further comparison, in studies of 173 dialysis facilities in
the United States, after adjusting for case-mix, facility vari-
ation accounted for only 7.1 % of the total variation with
respect to AVF use [18] and 6.7 % of the total variation
with respect to dialysis adequacy [19].
Numerous factors may account for facility and regional
variation in the use of NTHCs relative to tunneled CVCs.
The likelihood of ‘suboptimal’ initiation of chronic dialy-
sis, defined as having a CVC (either a tunneled catheter or
NTHC) as initial vascular access maybe increased by sys-
temic and resource limitations that affect access to timely
AVF and AVG creation [8, 37, 38]. Similar considerations
likely account for some of the variation observed for initial
Table 1 Baseline patient, facility and geographic characteristics of the study cohort according to individuals who initiated dialysis
with non-tunneled temporary vs. tunneled hemodialysis catheters (Continued)
< 50 km 73.8 76.7
50-150 16.2 15.4
> 150 10.0 7.9
Facility Characteristics* (N = 61)
Mean number of incident patients (per year) 51.3 ± 34.4 60.0 ± 42.4 <0.0001
Transplant facility % 47.7 52.3 <0.0001
Peritoneal dialysis facility % 45.9 54.1 <0.0001
Mean eGFR at dialysis initiation (± SD) 9.7 ± 1.1 9.6 ± 1.2 0.001
Mean Hemoglobin g/L (± SD) 102.0 ± 3.5 102.0 ± 3.4 0.256
Mean Phosphate mmol/L (± SD) 1.9 ± 0.1 1.9 ± 0.1 0.002
Mean distance from facility km (± SD) 56.3 ± 40.7 50.0 ± 39.6 <0.0001
N Number, SD standard deviation, BMI body mass index, IQR intra-quartile range, CABG coronary artery bypass graft, ESRD end-stage renal disease, g/L grams per
liter, mmol/L millimole per liter, AVF arteriovenous fistula, eGFR estimated glomerular filtration rate in ml/min/1.73 m2 by the 4 variable MDRD equation,
km kilometer
Fig. 1 NTHC use as a percentage of crude CVC use at dialysis initiation, by geographic region. AB, Alberta; BC, British Columbia; MB, Manitoba; SK,
Saskatchewan; ON, Ontario
Clark et al. BMC Nephrology  (2016) 17:20 Page 5 of 11
Table 2 Multi-level model analysis of the unadjusted and adjusted variation at the facility and geographic-level for the initiation of
dialysis with a non-tunneled temporary hemodialysis catheter
Intra-class correlation (%) Variance estimate Standard error P value
Unadjusted
Facility 43.9 1.44 0.30 <0.0001
Geography 21.8 0.72 0.43 0.1
Fully adjusted
Facility 40.0 1.32 0.30 <0.0001
Geography 34.1 1.12 0.68 0.1
Geographic regions: 13; Facilities: 61; Patients:21,052
Adjusted for patient-level variables: age, sex, co-morbidities (CVA, angina, PVD, MI, Cancer, Pulmonary edema, COPD, DM, HTN, serious illness, CABG), body-mass
index, laboratory values, distance from dialysis facility, cause of ESRD, race, eGFR at dialysis initiation and facility-level variables: % transplant facility, % peritoneal
dialysis facility, and mean facility laboratory values, mean eGFR at dialysis initiation, mean distance from facility, mean facility size
Fig. 2 Adjusted odds ratio (with 95%CI) for initiation of hemodialysis with a NTHC across geographic regions of Canada. Adjusted for patient-level
variables: age, sex, co-morbidities (CVA, angina, PVD, MI, Cancer, Pulmonary edema, COPD, DM, HTN, serious illness, CABG), BMI, laboratory values,
distance from dialysis facility, cause of ESRD, race, eGFR at dialysis initiation and facility-level variables: % transplant facility, % peritoneal dialysis facility,
and mean facility laboratory values, mean eGFR at dialysis initiation, mean distance from facility, mean facility size. The image was modified
from http://allfreeprintable.com
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Table 3 Comparative patient and facility characteristics among facilities with the highest and lowest quartile of NTHC use at dialysis
initiation
Characteristic
Lowest quartile NTHC Highest quartile NTHC P Value
N 5013(51.9) 4651(48.1)
% with temp CVC 24.8 75.2
Age (mean ± SD) 64.0 ± 15.5 64.8 ± 15.6 0.01
Sex % male 57.9 59.2 0.395
BMI (mean ± SD) 27.4 ± 6.7 27.6 ± 6.8 0.123
Race (%) <0.001
Caucasian 70.9 74.2
East Asian 5.9 5.1
Aboriginal 7.8 6.1




Pre-dialysis care >90 days % 61.1 56.8 <0.0001
Pre-dialysis care >365 days % 42.3 38.1 <0.0001
Co-morbidities %
Acute coronary syndrome 26.3 25.1 0.177
Pulmonary edema 33.1 29.9 0.001
Diabetes mellitus 48.8 44.0 <0.001
Stroke 14.9 16.9 0.006
Peripheral vascular disease 21.2 23.0 0.035
Malignancy 14.9 15.9 0.150
Lung disease 13.7 14.6 0.179
Hypertension medications 85.0 77.8 <0.001
Current smoker 14.8 19.3 <0.001
CABG 13.3 14.7 0.056
Serious Illness 14.5 16.3 0.015
Angina 26.4 24.4 0.03
Cause of ESRD % <0.001
Hypertension 22.0 23.4




Polycystic kidney disease 2.8 2.0
Other 8.0 20.5
Unknown 10.0 10.3
eGFR at dialysis initiation (mean ± SD) 9.4 ± 4.5 9.8 ± 4.6 <0.0001
Hemoglobin g/L (mean ± SD) 97.9 ± 17.3 98.2 ± 17.8 0.341
Phosphate mmol/L (mean ± SD) 2.0 ± 0.7 2.0 ± 0.7 <0.0001
Albumin g/L (mean ± SD) 31.3 ± 0.9 29.8 ± 0.9 <0.0001
Distance from facility % <0.0001
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use of NTHCs versus tunneled CVCs across centers and
regions. For example, centers that have better access to
interventional radiology services or nephrologists and
trainees capable of inserting tunneled catheters themselves
may be less likely to start patients on dialysis using
NTHCs. Some authors have even suggested that the need
to provide training opportunities in NTHC insertion to
nephrology fellows could result in the “tendency to place a
non-tunneled catheter when a tunneled catheter might be
more appropriate” [39]. While no jurisdiction in Canada
charges patients for dialysis-related services, provider re-
muneration is determined at the provincial level and could
influence practice patterns amongst nephrologists, vascu-
lar surgeons, intensivists and interventional radiologists
accordingly.
Given that many patients begin dialysis with an NTHC
in the context of severe AKI and then may become
chronic HD patients in the event of non-recovery, center
level variation might be accounted for to some degree by
whether or not facilities have acute RRT capability. It is
a limitation of this study that details regarding centers’
capability to provide acute RRT were not available to be
included in the model; nonetheless, given that all regions
have secondary or tertiary referral centers that provide
RRT for patients with AKI in that region, regional vari-
ation is unlikely to be explained on the basis of acute
RRT capability. However, regional variation in the inci-
dence of dialysis-requiring AKI has been demonstrated
in the United States [40] and similar variation in Canada
could at least partially account for regional differences in
the propensity for NTHC use.
Notably, similarly pronounced center-level and re-
gional variation was observed for the subset of patients
who had received > 1 year of pre-dialysis nephrology
care. It has been shown that suboptimal initiation of
dialysis—defined as initiation as an inpatient and/or
using a CVC—frequently occurs despite an adequate
duration of pre-dialysis nephrology care [19, 38, 41–43]
and is associated with increased mortality [42, 44]. We
suggest that, in the context of having received an adequate
duration of pre-dialysis nephrology care, initiation of
chronic dialysis with an NTHC is even worse than ‘sub-
optimal’; it is ‘least-optimal’. This is because NTHC inser-
tion in this situation represents an additional procedure
carrying risks of serious complications [3] for patients
who will require a procedure to establish permanent vas-
cular access anyway. In addition, likely related to conse-
quent central venous stenosis [1], there is some evidence
to suggest that initial use of an NTHC is associated with
later vascular access complications such as AVF throm-
bosis [5]. Determining the causes of the unnecessary
NTHC use signaled by the wide degree of practice vari-
ation could potentially lead to improved pre-dialysis care
that diminishes ‘least-optimal’ dialysis starts.
A particular strength of our study is that data was de-
rived from a large, representative cohort of incident dialy-
sis patients from across Canada (excluding the province of
Québec which does not contribute to CORR data). We
utilized multi-level models and the intra-class correlation
coefficient to quantitate the relative explained variation at
individual levels, an analytic strategy that accounts for cor-
relation of observations within clusters. As Canada offers
universal public health care, there would be no bias due to
unaffordability of health care, vascular access or dialysis
services. There was little missing data on vascular ac-
cess at dialysis initiation (<7 %) thus our findings are
generalizable with limited selection bias.
This study has important limitations related to the use
of registry data that did not include information regarding
the indication for dialysis initiation including whether or
not it was conducted specifically in the setting of AKI.
Furthermore, while CORR registry data has been validated
Table 3 Comparative patient and facility characteristics among facilities with the highest and lowest quartile of NTHC use at dialysis
initiation (Continued)
< 50 km 75.2 72.0 <0.0001
50-150 18.6 16.6
> 150 6.2 11.4
Facility Characteristics
Mean number of incident patients (per year) 78.8 ± 30.3 68.6 ± 35.4 <0.0001
Transplant facility % 31.6 28.4 0.001
Peritoneal dialysis facility % 99.6 70.5 <0.0001
eGFR at dialysis initiation (facility mean ± SD) 9.7 ± 1.1 9.6 ± 1.2 0.001
Hemoglobin g/L (facility mean ± SD) 101.6 ± 3.5 101.7 ± 4.2 0.176
Phosphate mmol/L (facility mean ± SD) 1.9 ± 0.2 1.9 ± 0.1 <0.0001
Distance from facility km (facility mean ± SD) 42.2 ± 34.7 66.9 ± 41.5 <0.0001
NTHC non-tunelled hemodialysis catheter, N Number, eGFR estimated glomerular filtration rate, SD standard deviation, BMI body mass index, IQR intra-quartile
range, CABG coronary artery bypass graft, ESRD end-stage renal disease, g/L grams per liter, mmol/L millimoles per liter, AVF arteriovenous fistula
eGFR was estimated glomerular filtration rate in ml/min/1.73 m2 by the 4 variable MDRD equation, km kilometer
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to have minimal risk of bias when used for clinical re-
search [22], the coding for ‘type of catheter’ used for inci-
dent dialysis treatment has not specifically been validated.
Patients with an AVF/AVG or a co-existent AVF/AVG
and CVC at initial dialysis were excluded and we did not
account for subsequent CVC use. A potentially high pro-
portion of patients may experience early AVF/AVG failure
and require CVC insertion. Additional limitations include
the lack of data pertaining to the anatomic location of
catheter insertions (e.g. internal jugular or femoral), where
catheters were placed in hospitals (e.g. intensive care unit,
ward, dialysis unit, radiology suite), and by which kinds of
physicians (e.g. interventional radiologists, nephrologists,
intensivists). A final limitation is that, while we attempted
Table 4 Variables associated with initiation of chronic hemodialysis with a NTHC
Variables Odds ratio 95 % Confidence interval
Level 2: Facility variables
Transplant Facility 0.97 0.41-2.30
Peritoneal Dialysis Facility 0.89 0.33-2.44
Mean facility Hemoglobin 0.96 0.89-1.05
Mean facility Phosphate 0.14 0.01-2.30
Mean facility eGFR at dialysis initiation 0.92 0.70-1.21
Mean distance from facility 1.00 0.99-1.01
Number of Patients 1.00 1.01 - 1.15
Level 1: Patient-level variables
Age 59 and Under vs. Age 74+ 0.96 0.88-1.05
Age 60 to 73 vs. Age 74+ 1.05 0.97-1.13
Male 1.10 1.03-1.18
BMI 1.00 0.99-1.00
Asian vs. Caucasian 0.91 0.78-1.06
Black vs. Caucasian 0.88 0.73-1.06
Indian Subcontinent vs. Caucasian 0.97 0.82-1.15
Aboriginal vs. Caucasian 0.93 0.80-1.07
Unknown vs. Caucasian 0.91 0.76-1.08




Acute coronary syndrome 1.06 0.97-1.16
Cancer 1.03 0.94-1.12
Pulmonary Edema 1.36 1.26-1.46
Lung disease 1.11 1.01-1.22
Diabetes 0.95 0.88-1.02
Hypertension 0.79 0.72-0.86
Serious Illness 1.07 0.98-1.17
CABG 0.98 0.89-1.08
Distance 50 to 150 vs <50 1.13 1.03-1.25




eGFR at dialysis initiation 1.02 1.01-1.03
Calendar Year 0.79 0.78-0.80
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to account for facility-level complexity of care by assessing
if facilities offered transplantation and/or peritoneal dialy-
sis programs, this is not a precise way to distinguish
tertiary and quaternary care facilities from others. This is
particularly relevant since such centres may also be more
likely to provide on-call interventional radiology service
and/or acute dialysis therapy for AKI, factors that might
affect the type of catheters being used (i.e. NTHC versus
tunneled CVC).
Conclusions
In conclusion, a significant proportion of the variation
in initial NTHC use in chronic hemodialysis patients is
explained at the facility and regional level. Given that
starting dialysis with a NTHC is even less optimal than
starting with a tunneled CVC, future studies are needed
to determine what underpins facility-level and regional-
level variation: an improved understanding of this vari-
ation could lead the way to a reduction in the frequency
of ‘least-optimal’ dialysis starts using NTHCs.
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